Journal of the Japanese Society of Pediatric Surgeons
Online ISSN : 2187-4247
Print ISSN : 0288-609X
ISSN-L : 0288-609X
The Basic and Clinical Study of Combination Chemotherapy With Angiotensin II and Cyclophoshamide
Naomi Ohnuma, Hideyo Takahashi, Takao Etoh, Masahiro Tanabe, Yutaka Kuriyama, Masahiko Maie, Yonejiro Nagai
Author information
JOURNAL FREE ACCESS

1985 Volume 21 Issue 5 Pages 771-776

Details
Abstract
Angiotensin II induced hypertensive chemotherapy has not been reported in malignant solid tumor of childhood. The purpose of this paper is to determine how to combine angiotensin II and cyclophosphamide which is masked compound, because cyclophosphamide has been frequently used for treatment of malignant solid tumor in childhood. Then the concentration of active type of cyclophosphamide in blood and tumor tissue were measured sequentially after injection of inactive type of cyclophosphamide intra venously to A/Jax mice bearing C-1300 neuroblastoma. The peak time which appeared active type of cyclophosphamide in blood and tumor tissue of A/Jax mice was 60 minutes after the injection of inactive type of cyclophosphamide. When angiotensine II induced hypertension was continued during 60 minutes after the injection of inactive type of cyclophosphamide followed above data, the effect of cyclophosphamide to C-1300 neuroblastoma in A/Jax mice were enhanced. This combination chemotherapy of angiotensin II and cyclophosphamide was applied to a 9 year old girl with rhabdomyosarcoma, who had lung metastasis and multiple dissemination of abdominal cavity. Followed this combination chemotherapy of angiotensin II, cyclophosphamide, vincristine and actinomycine D, her abdominal circumference was decreased sooner than after simple type of VAC chemotherapy.
Content from these authors
© 1985 The Japanese Society of Pediatric Surgeons

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 継承 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-sa/4.0/deed.ja
Previous article Next article
feedback
Top